Comment on FDA approves cure for sickle cell disease, the first treatment to use CRISPR
chitak166@lemmy.world 9 months agoYeah, great points. Economies of scale have not kicked in, and I’m sure there are plenty of inefficiencies with the technologies they’re currently using.
owlboy@lemmy.world 9 months ago
It would be neat to know precisely what parts are expensive. Broad generalizations about how prices on goods go up and down aren’t quite as interesting. 😅
thoughtorgan@lemmy.world 9 months ago
CliniMACS plus/prodigy, LOVO, G-Rrex and other expensive instruments.
Grade B suites with grade A BSC’s and all the trained personnel to work on it.
Shit costs a lot of money.